OPT
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
524.82M
20 days until earnings call
Intraday BUY SELL Signals
QLGN
Price
$2.53
Change
-$0.12 (-4.53%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
5.14M
Intraday BUY SELL Signals
Interact to see
Advertisement

OPT vs QLGN

Header iconOPT vs QLGN Comparison
Open Charts OPT vs QLGNBanner chart's image
Opthea
PriceLoading...
Change-$0.00 (-0.00%)
Volume$3.03K
Capitalization524.82M
Qualigen Therapeutics
Price$2.53
Change-$0.12 (-4.53%)
Volume$1.7K
Capitalization5.14M
OPT vs QLGN Comparison Chart in %
OPT
Daily Signal:
Gain/Loss:
QLGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OPT vs. QLGN commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPT is a StrongBuy and QLGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (OPT: $3.41 vs. QLGN: $2.65)
Brand notoriety: OPT and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OPT: 100% vs. QLGN: 4%
Market capitalization -- OPT: $524.82M vs. QLGN: $5.14M
OPT [@Biotechnology] is valued at $524.82M. QLGN’s [@Biotechnology] market capitalization is $5.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPT’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 2 green FA rating(s).

  • OPT’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 2 green, 3 red.
According to our system of comparison, QLGN is a better buy in the long-term than OPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPT’s TA Score shows that 1 TA indicator(s) are bullish while QLGN’s TA Score has 3 bullish TA indicator(s).

  • OPT’s TA Score: 1 bullish, 0 bearish.
  • QLGN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, OPT is a better buy in the short-term than QLGN.

Price Growth

OPT (@Biotechnology) experienced а 0.00% price change this week, while QLGN (@Biotechnology) price change was +0.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

OPT is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPT($525M) has a higher market cap than QLGN($5.14M). OPT YTD gains are higher at: -13.176 vs. QLGN (-37.055). QLGN has higher annual earnings (EBITDA): -6.28M vs. OPT (-218.88M). OPT has more cash in the bank: 132M vs. QLGN (332K). QLGN has less debt than OPT: QLGN (3.62M) vs OPT (157M). OPT has higher revenues than QLGN: OPT (87.7K) vs QLGN (0).
OPTQLGNOPT / QLGN
Capitalization525M5.14M10,206%
EBITDA-218.88M-6.28M3,483%
Gain YTD-13.176-37.05536%
P/E RatioN/A0.40-
Revenue87.7K0-
Total Cash132M332K39,759%
Total Debt157M3.62M4,341%
FUNDAMENTALS RATINGS
OPT vs QLGN: Fundamental Ratings
OPT
QLGN
OUTLOOK RATING
1..100
4894
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7264
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (22) in the null industry is significantly better than the same rating for OPT (92). This means that QLGN’s stock grew significantly faster than OPT’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as OPT (100). This means that QLGN’s stock grew similarly to OPT’s over the last 12 months.

QLGN's SMR Rating (100) in the null industry is in the same range as OPT (100). This means that QLGN’s stock grew similarly to OPT’s over the last 12 months.

QLGN's Price Growth Rating (64) in the null industry is in the same range as OPT (72). This means that QLGN’s stock grew similarly to OPT’s over the last 12 months.

QLGN's P/E Growth Rating (1) in the null industry is significantly better than the same rating for OPT (100). This means that QLGN’s stock grew significantly faster than OPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPTQLGN
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OPT
Daily Signal:
Gain/Loss:
QLGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMDDX19.500.01
+0.05%
Principal Small-MidCap Dividend Inc C
RSPYX31.25-0.01
-0.03%
Victory RS Partners Y
GSAOX19.09-0.02
-0.10%
Goldman Sachs Small Cap Gr Insghts A
JHBCX72.11-0.08
-0.11%
JHancock Blue Chip Growth NAV
VRKSX10.65-0.02
-0.19%
Virtus KAR Small-Mid Cap Growth R6

OPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPT has been loosely correlated with TNYA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OPT jumps, then TNYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPT
1D Price
Change %
OPT100%
N/A
TNYA - OPT
37%
Loosely correlated
+8.45%
PSTV - OPT
35%
Loosely correlated
-2.25%
CYTK - OPT
27%
Poorly correlated
-0.84%
KYTX - OPT
26%
Poorly correlated
+4.71%
QLGN - OPT
25%
Poorly correlated
+1.15%
More